The beginnings of stereotactic and functional neurosurgery can be traced as far back as 1873 when Dittmar reported the use of a guiding device for the placement of probes into the medulla oblongata in animals. Further pioneering work was done by Zernov and Altukhov in Russia (1889), Clarke and Horsley in England (1908), and Spiegel and Wycis in the United States (1947), as well as others. After a promising initiation, interest in stereotactic neurosurgery waned after the introduction of L-dopa in the 1960s. Later, the introduction and incorporation of new imaging technology into stereotactic techniques signaled the rebirth of stereotactic and functional neurosurgery as a versatile and exciting subspecialty not only in the resection of previously unresectable lesions but also in the functional restoration of central nervous system function. This brief paper will focus on the personalities that have pioneered stereotactic neurosurgery over the past century.

Keywords:
Stereotactic neurosurgery, Neurosurgery history, Horsley, Medicine history, Surgical instruments
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.